{"name":"ALEMBIC PHARMS LTD","slug":"alembic-pharms-ltd","ticker":"","exchange":"","domain":"alembicpharms.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":1041000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[{"name":"Pristiq","genericName":"desvenlafaxine","slug":"desvenlafaxine","revenue":1041000000,"yoyGrowth":0,"percentOfTotal":100}],"timeline":[{"date":"2008-01-01","label":"Pristiq first approved","drug":"Pristiq","drugSlug":"desvenlafaxine","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":1041000000,"percentOfTotal":100,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Pristiq","genericName":"desvenlafaxine","slug":"desvenlafaxine","indication":"Major depressive disorder","status":"marketed","revenue":1041000000}]}],"pipeline":[{"name":"Pristiq","genericName":"desvenlafaxine","slug":"desvenlafaxine","phase":"marketed","mechanism":"Pristiq works by blocking the reabsorption of serotonin and norepinephrine in the brain, allowing more of these neurotransmitters to be available for use.","indications":["Major depressive disorder"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}